Moderna COVID-19 vaccine (Spikevax) authorised for use in infants and children aged 6 months to 5 years

The COVID-19 vaccine from Moderna has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group

Read the original advice at Foreign Travel Advice (UK)